Delivery Order SPE2DB22D3016-SPE2DB25FASF5
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALVANCE 500 MG VIALS. The $5,377.68 firm fixed price contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568345157 DALVANCE 500 MG VIALS, with a ceiling value of $8,962.70 and a completion date of May 27, 2025. The contract is a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALVANCE 500 MG VIALS. The contract has a total ceiling value of $9,478.32 and a performance period through April 2025. It is a firm fixed price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALVANCE 500 MG VIALS, a specialty pharmaceutical product, with a ceiling value of $1,800.05 and a performance period ending on May 21, 2024. The contract was awarded on May 20, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,066.43, is for the supply of 4,568,058,088 units of the pharmaceutical product DALVANCE 500 MG VIALS. The contract has a firm fixed price and is not set aside. It has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,165.69 award is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DALVANCE 500 MG VIALS, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $31,285.60. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dalvance 500 mg vials. The contract has a firm fixed price, a ceiling value of $8,962.70, and a period of performance through April 23, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.56 firm fixed-price contract is for the delivery of 4,567,865,750 units of the drug DALVANCE 500 MG VIALS. The contract has an ultimate completion date of April 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $6,474.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, with a completion date of February 19, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...